Fiji vs Singapore: Coverage of the human papillomavirus vaccine
Fiji
70
in 2025
Singapore
71
in 2025
Fiji rank
41st
Singapore rank
39th
Coverage of the human papillomavirus vaccine over time
- Fiji
- Singapore
How they compare
Singapore currently reports 71 against 70 in Fiji, a difference of 1.
The two have swapped places 1 time across 11 shared years of data; in 2015 it was Fiji ahead.
Fiji ranks 41st and Singapore ranks 39th of 85 countries.
Across the 2 decades both report, Fiji averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Fiji | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 60 | 0.6 | 59.4 | Fiji |
| 2020s | 54.67 | 65.5 | 10.83 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, Fiji or Singapore?
- Singapore, at 71 against 70 in Fiji as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between Fiji and Singapore?
- 1, with Singapore ahead.
- How many years of comparable data are there for Fiji and Singapore?
- 11 years are reported by both, from 2015 to 2025.
- How do Fiji and Singapore rank globally for coverage of the human papillomavirus vaccine?
- Fiji ranks 41st and Singapore ranks 39th of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.